Table of Content

1 INTRODUCTION 12
1.1 STUDY OBJECTIVES 12
1.2 MARKET DEFINITION 12
1.2.1 INCLUSIONS & EXCLUSIONS 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
FIGURE 1 US SURGICAL PROCEDURES MARKET 13
1.3.2 YEARS CONSIDERED 13
1.4 STAKEHOLDERS 14
1.5 UNITS CONSIDERED 14
1.6 SUMMARY OF CHANGES 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.2 RESEARCH METHODOLOGY STEPS 15
FIGURE 2 RESEARCH METHODOLOGY: US SURGICAL PROCEDURES MARKET 15
FIGURE 3 RESEARCH DESIGN 16
2.2.1 SECONDARY DATA 16
2.2.1.1 Key secondary sources 16
2.2.2 PRIMARY DATA 18
2.2.2.1 Key insights from primary sources 19
2.3 MARKET ESTIMATION 19
FIGURE 4 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 21
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
2.5 STUDY ASSUMPTIONS 23
2.6 RISK ASSESSMENT 23
TABLE 1 RISK ASSESSMENT: US SURGICAL PROCEDURES MARKET 23
2.7 LIMITATIONS 24
2.8 IMPACT OF COVID-19 ON US SURGICAL PROCEDURES MARKET 24
2.9 RECESSION IMPACT: US SURGICAL PROCEDURES MARKET 25
FIGURE 6 US HEALTHCARE INFLATION-PERCENT INCREASE 25
3 EXECUTIVE SUMMARY 26
FIGURE 7 US SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 26
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 27
FIGURE 9 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 27
FIGURE 10 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 28
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 28
FIGURE 12 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 29
FIGURE 13 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 29
FIGURE 14 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 30
FIGURE 15 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 30
FIGURE 16 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 31
FIGURE 17 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2023 VS. 2028 (THOUSAND PROCEDURES) 32
4 PREMIUM INSIGHTS 33
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 33
FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 33
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE & CHANNEL 34
FIGURE 19 DENTAL SURGICAL PROCEDURES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 34
4.3 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE 35
FIGURE 20 INPATIENT SURGERIES TO DOMINATE MARKET OVER FORECAST PERIOD 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
FIGURE 21 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
5.2.1 DRIVERS 37
5.2.1.1 Growing prevalence of cancer requiring surgical treatment 37
FIGURE 22 US: ESTIMATED NEW CASES AND DEATHS FOR EACH COMMON CANCER TYPE IN 2023 37
FIGURE 23 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 38
FIGURE 24 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 38
5.2.1.2 Growth in geriatric population and rise in chronic disease prevalence 39
FIGURE 25 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 40
5.2.1.3 Increasing rate of organ transplantation 41
TABLE 2 US: SINGLE-ORGAN TRANSPLANTS PERFORMED, 2016–2020 41
5.2.1.4 Technological advancements in surgical procedures 41
FIGURE 26 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 42
5.2.2 OPPORTUNITIES 43
5.2.2.1 Increasing adoption of outpatient surgeries 43
5.2.2.2 Improved surgical techniques in bariatric procedures 43
TABLE 3 BARIATRIC SURGERIES PERFORMED, 2016–2020 44
5.2.3 CHALLENGES 44
5.2.3.1 Surgical errors 44
5.2.3.2 Complications associated with surgical procedures 45
TABLE 4 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 46
5.2.3.3 Shortage of surgeons 47
6 INDUSTRY INSIGHTS 48
6.1 INDUSTRY TRENDS 48
6.1.1 MINIMALLY INVASIVE SURGERY 48
6.1.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 49
6.2 PRICING ANALYSIS 49
TABLE 5 TYPICAL AVERAGE COSTS FOR SOME COMMON SURGERIES 50
6.3 REIMBURSEMENT SCENARIO 51
TABLE 6 LIST OF SURGICAL PROCEDURE CODES 52
TABLE 7 COSMETIC SURGERY PROCEDURE CODES 53
6.4 TECHNOLOGY ANALYSIS 53
6.5 REGULATORY LANDSCAPE 54
7 US SURGICAL PROCEDURES MARKET, BY TYPE 55
7.1 INTRODUCTION 56
TABLE 8 US SURGICAL PROCEDURES MARKET, BY TYPE, 2021–2028 (THOUSANDS) 56
7.2 DENTAL SURGICAL PROCEDURES 57
7.2.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH 57
TABLE 9 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 58
7.3 ORTHOPEDIC SURGICAL PROCEDURES 58
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED DEVICES TO INCREASE PROCEDURAL VOLUMES 58
TABLE 10 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 59
7.4 GASTROINTESTINAL SURGICAL PROCEDURES 60
7.4.1 INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES TO BOOST MARKET 60
FIGURE 27 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 61
TABLE 11 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 61
?
7.5 OPHTHALMIC SURGICAL PROCEDURES 62
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY TO DRIVE DEMAND FOR OPHTHALMIC SURGERY 62
TABLE 12 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 63
7.6 CARDIOVASCULAR SURGICAL PROCEDURES 63
7.6.1 RISING PREVALENCE OF HEART DISEASE TO BOOST DEMAND FOR SURGERY 63
TABLE 13 US: NUMBER OF CVD CASES, 2015–2035 (MILLION) 64
TABLE 14 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 65
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 65
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES TO DRIVE MARKET GROWTH 65
TABLE 15 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 66
7.8 COSMETIC SURGICAL PROCEDURES 67
7.8.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES TO PROPEL ADOPTION OF COSMETIC SURGERIES 67
TABLE 16 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 68
7.9 ENT SURGICAL PROCEDURES 68
7.9.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY TO BOOST GROWTH OF ENT SURGICAL PROCEDURES 68
TABLE 17 US: ENT SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 69
7.10 UROLOGIC SURGICAL PROCEDURES 69
7.10.1 INCREASING KIDNEY DISEASE INCIDENCE TO BOOST PROCEDURAL VOLUME 69
TABLE 18 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 70
7.11 OTHER SURGICAL PROCEDURES 71
TABLE 19 US: OTHER SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 71
TABLE 20 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 72
TABLE 21 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 72
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 73
8.1 INTRODUCTION 74
TABLE 22 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2021–2028 (THOUSANDS) 74
8.2 PHYSICIAN OFFICES 74
8.2.1 PHYSICIAN OFFICES TO DOMINATE END-USER MARKET DUE TO TECHNOLOGICAL ADVANCES AND GROWING FEASIBILITY 74
?
8.3 HOSPITALS 75
TABLE 23 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 75
TABLE 24 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2021–2028 (THOUSANDS) 76
8.3.1 INPATIENT SURGERIES 76
8.3.1.1 Increasing incidence of cardiovascular, neurological, and intestinal disorders to drive market growth 76
8.3.2 OUTPATIENT SURGERIES 76
8.3.2.1 Convenience and lower cost to boost demand for outpatient surgeries 76
8.4 AMBULATORY SURGERY CENTERS 77
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH 77
9 APPENDIX 79
9.1 DISCUSSION GUIDE 79
9.2 KNOWLEDGESTORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 84
9.3 RELATED REPORTS 86
9.4 AUTHOR DETAILS 87